Whether influenza vaccination in solid-organ transplant recipients is efficacious remains a
controversial issue. Furthermore, theoretical concerns have been raised regarding the safety …

BACKGROUND: Antibody response to the inactivated influenza vaccine is not well
described in kidney transplant recipients administered newer, but commonly used …

Salles MJC, Sens YAS, Boas LSV, Machado CM. Influenza virus vaccination in kidney
transplant recipients: serum antibody response to different immunosuppressive drugs. Clin …

Background The use of vaccines with higher doses of antigen is an attractive strategy to
improve the immunogenicity of influenza vaccination in transplant recipients. However, the …

It has been speculated that influenza vaccination of renal allograft recipients could be
associated withde novo production and/or increased titers of anti-HLA antibodies (HLA-Ab) …

Results There were 9678 (18.7%) patients with claims for influenza vaccination in the first
year post-transplant. Factors associated with vaccination included older age, diabetes, later …

Background. Due to possible complications and treatment limitations, the prevention of
influenza in renal transplant (RT) patients is highly indicated. Methods. Forty-nine patients …

Preventing influenza infection early after transplantation is essential, given the disease's
high mortality. A multicentre prospective cohort study in adult solid organ transplant …

Influenza vaccination is widely used in transplant recipients, but there is little known about
the significance and correlating factors of its effectiveness. In the current study, we reviewed …

Influenza virus causes a spectrum of illness in transplant recipients with a high rate of lower
respiratory disease. Seasonal influenza vaccination is an important public health measure …